Published in J Neurovirol on May 10, 2011
Mapping white matter integrity in elderly people with HIV. Hum Brain Mapp (2013) 1.05
Disrupted cerebral metabolite levels and lower nadir CD4 + counts are linked to brain volume deficits in 210 HIV-infected patients on stable treatment. Neuroimage Clin (2013) 1.01
The effects of HIV and combination antiretroviral therapy on white matter integrity. AIDS (2012) 0.93
Patterns of white matter injury in HIV infection after partial immune reconstitution: a DTI tract-based spatial statistics study. J Neurovirol (2012) 0.92
Role of neuroimaging in HIV-associated neurocognitive disorders. Semin Neurol (2014) 0.88
Neuroimaging of HIV-associated neurocognitive disorders (HAND). Curr Opin HIV AIDS (2014) 0.88
Brain alterations within the first 100 days of HIV infection. Ann Clin Transl Neurol (2014) 0.87
Cerebral white matter integrity during primary HIV infection. AIDS (2015) 0.85
Determinants of HIV-induced brain changes in three different periods of the early clinical course: A data mining analysis. Neuroimage Clin (2015) 0.83
Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART. J Neurovirol (2014) 0.82
Altered Oligodendrocyte Maturation and Myelin Maintenance: The Role of Antiretrovirals in HIV-Associated Neurocognitive Disorders. J Neuropathol Exp Neurol (2015) 0.77
Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage (1999) 40.38
Updated research nosology for HIV-associated neurocognitive disorders. Neurology (2007) 16.18
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet (2009) 14.01
Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. J Infect Dis (2008) 6.73
The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science (1988) 6.51
Hand and sex differences in the isthmus and genu of the human corpus callosum. A postmortem morphological study. Brain (1989) 5.96
The AIDS dementia complex: II. Neuropathology. Ann Neurol (1986) 5.61
The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS (2007) 5.18
HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol (2002) 4.20
Human immunodeficiency virus-associated dementia: an evolving disease. J Neurovirol (2003) 2.93
Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline. Proc Natl Acad Sci U S A (2005) 2.79
3D pattern of brain atrophy in HIV/AIDS visualized using tensor-based morphometry. Neuroimage (2006) 2.69
Effects of methamphetamine dependence and HIV infection on cerebral morphology. Am J Psychiatry (2005) 2.34
Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol (2007) 2.27
A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age. Neuroimage (2004) 2.05
Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment. AIDS (2011) 2.04
Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era. J Neurovirol (2010) 1.95
3D mapping of ventricular and corpus callosum abnormalities in HIV/AIDS. Neuroimage (2006) 1.93
Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients. AIDS Res Hum Retroviruses (2008) 1.84
Diffusion tensor imaging with quantitative fibre tracking in HIV infection and alcoholism comorbidity: synergistic white matter damage. Brain (2006) 1.83
Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy. Arch Neurol (2004) 1.79
Whole brain diffusion tensor imaging in HIV-associated cognitive impairment. AJNR Am J Neuroradiol (2004) 1.78
Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection--The Hawaii Aging with HIV Cohort. J Neurovirol (2006) 1.76
Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group. Arch Neurol (1998) 1.66
Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in China. AIDS (2010) 1.66
Correlation of in vivo neuroimaging abnormalities with postmortem human immunodeficiency virus encephalitis and dendritic loss. Arch Neurol (2004) 1.65
Evidence for ongoing brain injury in human immunodeficiency virus-positive patients treated with antiretroviral therapy. J Neurovirol (2009) 1.57
The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection. Arch Neurol (1987) 1.57
White matter abnormalities revealed by diffusion tensor imaging in non-demented and demented HIV+ patients. Neuroimage (2009) 1.52
Diffusion alterations in corpus callosum of patients with HIV. AJNR Am J Neuroradiol (2006) 1.49
Diffusion tensor imaging in normal aging and neuropsychiatric disorders. Eur J Radiol (2003) 1.44
Diffusion tensor imaging of subcortical brain injury in patients infected with human immunodeficiency virus. J Neurovirol (2005) 1.42
The Neuropathology of HIV/AIDS. Int Rev Psychiatry (2008) 1.41
Regional patterns of brain metabolites in AIDS dementia complex. Neuroimage (2004) 1.40
Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia. Am J Psychiatry (1995) 1.38
Neurobiology of HIV. Int Rev Psychiatry (2008) 1.38
Relationships between cognition and structural neuroimaging findings in adults with human immunodeficiency virus type-1. Neurosci Biobehav Rev (2002) 1.36
Contribution of alcoholism to brain dysmorphology in HIV infection: effects on the ventricles and corpus callosum. Neuroimage (2006) 1.31
HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients. AIDS (2007) 1.25
Frontostriatal fiber bundle compromise in HIV infection without dementia. AIDS (2009) 1.25
Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes. J Neurovirol (2010) 1.22
Mapping structural differences of the corpus callosum in individuals with 18q deletions using targetless regional spatial normalization. Hum Brain Mapp (2005) 1.18
A multicenter study of two magnetic resonance spectroscopy techniques in individuals with HIV dementia. J Magn Reson Imaging (2005) 1.17
Lower CD4+ T lymphocyte nadirs may indicate limited immune reconstitution in HIV-1 infected individuals on potent antiretroviral therapy: analysis of immunophenotypic marker results of AACTG 5067. J Clin Immunol (2005) 1.06
Central nervous system dysfunction in acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr (1988) 1.05
Quantitative diffusion tensor imaging tractography metrics are associated with cognitive performance among HIV-infected patients. Brain Imaging Behav (2010) 1.01
Human immunodeficiency virus infection, inducible nitric oxide synthase expression, and microglial activation: pathogenetic relationship to the acquired immunodeficiency syndrome dementia complex. Ann Neurol (1999) 0.96
Brain atrophy in HIV infection is more strongly associated with CDC clinical stage than with cognitive impairment. J Int Neuropsychol Soc (1997) 0.95
Alcoholism and AIDS: magnetic resonance imaging approaches for detecting interactive neuropathology. Alcohol Clin Exp Res (2002) 0.94
White matter changes in HIV-1 infected brains: a combined gross anatomical and ultrastructural morphometric investigation of the corpus callosum. Clin Neurol Neurosurg (2009) 0.90
Corpus callosum: multiple parameter measurements in rodents and humans. Physiol Behav (1991) 0.86
Traumatic brain injury, alcohol and quantitative neuroimaging: preliminary findings. Brain Inj (1996) 0.81
Head trauma and intellectual status: relation to quantitative magnetic resonance imaging findings. Appl Neuropsychol (1999) 0.76
A protein interaction map of Drosophila melanogaster. Science (2003) 20.06
Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med (1997) 10.62
Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med (2002) 9.70
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 9.61
Patients' views on identifiability of samples and informed consent for genetic research. Am J Bioeth (2008) 5.73
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy. N Engl J Med (2009) 4.54
HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol (2002) 4.20
Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1. J Infect Dis (2005) 3.93
ADHD and epilepsy in childhood. Dev Med Child Neurol (2003) 3.83
Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings. Clin Infect Dis (2009) 3.76
Diffusion tensor imaging of the corpus callosum in Autism. Neuroimage (2006) 3.48
Elevated body mass index is associated with executive dysfunction in otherwise healthy adults. Compr Psychiatry (2006) 3.48
Estimating probit models with self-selected treatments. Stat Med (2006) 3.31
Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients. Hepatology (2008) 3.14
Head circumference and height in autism: a study by the Collaborative Program of Excellence in Autism. Am J Med Genet A (2006) 3.01
Insulin-like growth factor-I in men with idiopathic osteoporosis. J Clin Endocrinol Metab (1997) 3.00
An overview of second generation biofuel technologies. Bioresour Technol (2009) 2.95
Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease. J Infect Dis (2004) 2.91
Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS (2009) 2.88
Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect Immun (1995) 2.87
Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population. J Infect Dis (2003) 2.54
Average daily blood pressure, not office blood pressure, is associated with progression of cerebrovascular disease and cognitive decline in older people. Circulation (2011) 2.50
Intravascular susceptibility contrast mechanisms in tissues. Magn Reson Med (1994) 2.48
Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy. J Infect Dis (2011) 2.44
Theoretical model for water diffusion in tissues. Magn Reson Med (1995) 2.43
Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology (1994) 2.41
Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infection. J Infect Dis (2011) 2.34
Decreased interhemispheric functional connectivity in autism. Cereb Cortex (2010) 2.33
Human immunodeficiency virus type 1 (HIV-1) diversity at time of infection is not restricted to certain risk groups or specific HIV-1 subtypes. J Virol (2004) 2.33
CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS (2011) 2.31
Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA. Arch Neurol (2002) 2.28
The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals. J Infect Dis (2011) 2.26
Lopinavir concentrations in cerebrospinal fluid exceed the 50% inhibitory concentration for HIV. AIDS (2005) 2.25
Condom use as a function of time in new and established adolescent sexual relationships. Am J Public Health (2002) 2.24
Accrual of MRI white matter abnormalities in elderly with normal and impaired mobility. J Neurol Sci (2005) 2.19
Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. J Infect Dis (2003) 2.16
Early adolescent exposure to alcohol advertising and its relationship to underage drinking. J Adolesc Health (2007) 2.15
Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging. Stroke (2008) 2.12
Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results. J Infect Dis (2011) 2.12
MRI in multiple sclerosis: current status and future prospects. Lancet Neurol (2008) 2.08
Lack of neutralizing antibody response to HIV-1 predisposes to superinfection. Virology (2006) 2.07
Equine rhinosporidiosis: an exotic disease in the UK. Vet Rec (2007) 2.07
Group II introns as controllable gene targeting vectors for genetic manipulation of bacteria. Nat Biotechnol (2001) 2.06
Demographically corrected norms for African Americans and Caucasians on the Hopkins Verbal Learning Test-Revised, Brief Visuospatial Memory Test-Revised, Stroop Color and Word Test, and Wisconsin Card Sorting Test 64-Card Version. J Clin Exp Neuropsychol (2011) 2.06
Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment. AIDS (2011) 2.04
Recovery from chronic factitious disorder (Munchausen's syndrome): a personal account. Personal Ment Health (2013) 2.04
Motor blocks in Parkinson's disease. Neurology (1992) 2.01
Effectiveness of first-line management strategies for stage I follicular lymphoma: analysis of the National LymphoCare Study. J Clin Oncol (2012) 1.99
Response to emotional expressions in generalized social phobia and generalized anxiety disorder: evidence for separate disorders. Am J Psychiatry (2008) 1.99
Recurrent seizures and behavior problems in children with first recognized seizures: a prospective study. Epilepsia (2002) 1.97
Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era. J Neurovirol (2010) 1.95
An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. Arch Neurol (2007) 1.94
Dark, bitter-tasting nectar functions as a filter of flower visitors in a bird-pollinated plant. Ecology (2006) 1.94
Incidence of HIV superinfection following primary infection. JAMA (2004) 1.92
Antiretroviral drug concentrations and HIV RNA in the genital tract of HIV-infected women receiving long-term highly active antiretroviral therapy. Clin Infect Dis (2008) 1.91
Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort. AIDS (2011) 1.90
Intrinsic contractility of lymphatics in sheep and in dogs. Q J Exp Physiol Cogn Med Sci (1973) 1.88
Molecular and pathologic insights from latent HIV-1 infection in the human brain. Neurology (2013) 1.88
3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine. Ann Intern Med (2000) 1.88
Diffusion tensor imaging of white matter in the superior temporal gyrus and temporal stem in autism. Neurosci Lett (2007) 1.84
Early effects of illumination on the activity of some photosynthetic enzymes. Plant Physiol (1967) 1.83
Impaired replication capacity of acute/early viruses in persons who become HIV controllers. J Virol (2010) 1.80
Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy. Arch Neurol (2004) 1.79
Social outcomes in childhood brain disorder: a heuristic integration of social neuroscience and developmental psychology. Psychol Bull (2007) 1.79
Sporadic Creutzfeldt-Jakob disease in a 16-year-old in the UK. Lancet (1995) 1.78
p53 rescue through HDM2 antagonism suppresses melanoma growth and potentiates MEK inhibition. J Invest Dermatol (2011) 1.77
Human immunodeficiency virus type 1 clade B superinfection: evidence for differential immune containment of distinct clade B strains. J Virol (2005) 1.77
Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families. PLoS One (2012) 1.76
A randomized controlled trial of therapeutic drug monitoring in treatment-naive and -experienced HIV-1-infected patients. J Acquir Immune Defic Syndr (2007) 1.76
HLA-B63 presents HLA-B57/B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus load. J Virol (2005) 1.76
Diffusion tensor imaging in autism spectrum disorder: a review. Autism Res (2012) 1.75
Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data. Ann Intern Med (2014) 1.75
Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change. J Clin Exp Neuropsychol (2011) 1.73
Transmission behaviors of recently HIV-infected men who have sex with men. J Acquir Immune Defic Syndr (2006) 1.73
Diffusion tensor imaging in the corpus callosum in children after moderate to severe traumatic brain injury. J Neurotrauma (2006) 1.72
Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection. AIDS (2013) 1.71
Deep gray matter involvement on brain MRI scans is associated with clinical progression in multiple sclerosis. J Neuroimaging (2009) 1.70
The efficacy of moderate-intensity exercise as an aid for smoking cessation in women: a randomized controlled trial. Nicotine Tob Res (2005) 1.70
Relationship between body mass index and brain volume in healthy adults. Int J Neurosci (2008) 1.69
Systemic hypoperfusion is associated with executive dysfunction in geriatric cardiac patients. Neurobiol Aging (2006) 1.69
Microstructural connectivity of the arcuate fasciculus in adolescents with high-functioning autism. Neuroimage (2010) 1.69
Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels. AIDS (2002) 1.68
Unprotected anal intercourse and substance use among men who have sex with men with recent HIV infection. J Acquir Immune Defic Syndr (2006) 1.66
Neurovascular coupling is impaired in slow walkers: the MOBILIZE Boston Study. Ann Neurol (2011) 1.66
Functional connectivity magnetic resonance imaging classification of autism. Brain (2011) 1.65
Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China. J Neurovirol (2008) 1.64